Hostname: page-component-848d4c4894-2xdlg Total loading time: 0 Render date: 2024-06-27T06:34:43.308Z Has data issue: false hasContentIssue false

The serotypes of Bordetella pertussis isolated in Great Britain between 1941 and 1968 and a comparison with the serotypes observed in other countries over this period

Published online by Cambridge University Press:  15 May 2009

Caroline J. Bronne–Shanbury
Affiliation:
The Lister Institute of Preventive Medicine, Elstree, Hertfordshire WD6 3AX
Delphine Miller
Affiliation:
The Lister Institute of Preventive Medicine, Elstree, Hertfordshire WD6 3AX
A. F. B. Standfast
Affiliation:
The Lister Institute of Preventive Medicine, Elstree, Hertfordshire WD6 3AX
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Classification, by agglutinogens, of 634 isolates of Bordetella pertussis collected from 1941 to 1968 in Great Britain demonstrated that a change from a predominantly 1,2,0,4 serotype (75% of those examined during 1941–4) to a predominantly 1,0,3,0 serotype (73% of those examined during 1966–8) occurred sometime after 1953. Furthermore, evidence from the examination of isolates collected between 1941 and 1953 suggests that the change may have been gradual. Isolates of serotype 1,2,3,4 made up 20–30% of the total of our cross-country selection for the periods 1941–4, 1946–9, 1950–3 and 1966–8, but over shorter periods in individual areas the percentage varied from negligible to as high as half of those isolated. Results from other countries show a similar drift towards a 1,0,3 serotype but more often from a 1,2,3 than from 1,2,0 serotype.

The value, in epidemiological studies, of extended information obtained by monospecific typing sera to all six, rather than only two or three agglutinogens, and confirmation of the results by agglutinin production is demonstrated: for instance not all 1,0,3 isolates were identical.

Type
Research Article
Copyright
Copyright © Cambridge University Press 1976

References

REFERENCES

Andersen, E. K. (1952). Serological studies on Haemophilus pertussia and Haemophilus bronchisepticus. Preliminary report. Acta pathologica et microbiologica scandinavica 30, 54–8.CrossRefGoogle Scholar
Andersen, E. K. (1953). Serological studies on Haemophilus pertussis and Haemophilus bronchisepticus. Acta pathologica et microbiologica scandinavica 33, 202–24.CrossRefGoogle Scholar
Andersen, E. K. (1966). Private communication to A. F. B. Standfast.Google Scholar
Blaskbett, A. C., Gulasekhaham, J. C. & Fulton, L. C. (1971). The occurrence of Bordetella pertussis serotypes in Australia 1950–1970. Medical Journal of Australia 1, 781–4.CrossRefGoogle Scholar
Bronne-Shanbury, C. J. (1976). The importance of agglutinin production in mice in determination of the definitive serotype of Bordetella pertussis. Journal of Hygiene 76, 257–64.CrossRefGoogle ScholarPubMed
Bronne-Shanbury, C. J. & Dolby, J. M. (1976). The stability of the serotypes of Bordetella pertussis with particular reference to serotype 1,2,3,4. Journal of Hygiene 76, 277–86.CrossRefGoogle ScholarPubMed
Cameron, J. (1967). Variation in Bordetella pertussis.Journal of Pathology and Bacteriology 94, 367–74.CrossRefGoogle ScholarPubMed
Chalvardjian, N. (1965). The content of antigens 1,2, and 3 in strains of Bordetella pertussis and in vaccines. Canadian Medical Association Journal 92, 1114–16.Google ScholarPubMed
Cohen, H. (1970). Effectiveness of pertussis vaccination in the Netherlands. International Symposium on pertussis, 1970. Symposia Series in Immunological Standardisation, no. 13.Google Scholar
Demina, A. A., Larina, L. I. & Devyatkina, N. P. (1968). The change of the serological type of the Pertussis causative agent. Zurnal Microbiologii, Epidemiologii, i Immunobiologii 2, 1316.Google Scholar
Dolby, J. M. & Bronne-Shanbury, C. J. (1975). The use of spheroplast-derived strains to differentiate between Bordetella pertussis heat-labile agglutinogens and protective antigen in mice. Journal of Biological Standardization 3, 89100.CrossRefGoogle Scholar
Eldering, G., Holwerda, J. & Baker, J. (1967). Mouse protective properties of Bordetella pertussis serotypes in passive tests. Journal of Bacteriology 93, 1758–61.CrossRefGoogle ScholarPubMed
Eldering, G., Holwerda, J., Davis, A. & Baker, J. (1969). Bordetella pertussis serotypes in the United States. Applied Microbiology 18, 618–21.CrossRefGoogle ScholarPubMed
Holt, L. B. (1968). Pitfalls in the preparation of monotypic agglutinating antisera for Bordetella pertussis. Journal of Medical Microbiology 1, 169–80.CrossRefGoogle ScholarPubMed
Maixnerova, M., Burianova-Vysoka, B. & Stansky, V. (1972). Surveillance of whooping cough in Czechoslovakia. II. Incidence of antigenic types of Bordetella pertussis in Czechoslovakia in years 1966–1970. Journal of Hygiene, Epidemiology, Microbiology and Immunology 16, 267–72.Google ScholarPubMed
Mebel, S. (1968). Zur Serologie von Bordetella pertussis I Verbreitung der Serotypen. Zentral-blatt für Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene, Abt. 1, Orig., 206, 481–5.Google Scholar
Preston, N. W. (1963). Type-specific immunity to whooping cough. British Medical Journal ii, 724–6.CrossRefGoogle Scholar
Preston, N. W. (1965). Effectiveness of pertussis vaccine. British Medical Journal ii, 1113.CrossRefGoogle Scholar
Preston, N. W. & Stanbridge, T. N. (1972). Efficacy of pertussis vaccines: a brighter horizon. British Medical Journal iii, 448–51.CrossRefGoogle Scholar
Public Health Laboratory Service (1969). Efficacy of whooping-cough vaccines used in the United Kingdom before 1968 – Preliminary report. British Medical Journal iv, 329–33.Google Scholar
Public Health Laboratory Service (1973). Efficacy of whooping-cough vaccines used in the United Kingdom before 1968. Final report. British Medical Journal i, 259–62.Google Scholar
Stanbridge, T. N. & Preston, N. W. (1974). Experimental pertussis infection in the marmoset: type specificity of active immunity. Journal of Hygiene 72, 213–28.CrossRefGoogle ScholarPubMed